Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mong Cho

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Nature Medicine|February 12, 2013
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancerJeong Heo, Tony Reid, Leyo Ruo, et al.
Journal of Gastroenterology|December 25, 2010
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, et al.
The American Journal of Gastroenterology|June 27, 2012
A prospective nationwide study of drug-induced liver injury in KoreaKi Tae Suk, Dong Joon Kim, Chang Hoon Kim, et al.
Digestive Diseases and Sciences|August 29, 2020
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyHye Kyung Hyun, Eun Ju Cho, Soo Young Park, et al.
Hepatology (Baltimore, Md.)|July 25, 2007
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionByung Chul Yoo, Ju Hyun Kim, Tae-Hun Kim, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis BByung Chul Yoo, Ju Hyun Kim, Young-Hwa Chung, et al.
Yonsei Medical Journal|December 31, 2020
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular CarcinomaJae Seung Lee, Young Eun Chon, Beom Kyung Kim, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Nature Medicine|February 12, 2013
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancerJeong Heo, Tony Reid, Leyo Ruo, et al.
Journal of Gastroenterology|December 25, 2010
Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapyHyo-Suk Lee, Byung Chul Yoo, Kwan Sik Lee, et al.
The American Journal of Gastroenterology|June 27, 2012
A prospective nationwide study of drug-induced liver injury in KoreaKi Tae Suk, Dong Joon Kim, Chang Hoon Kim, et al.
Digestive Diseases and Sciences|August 29, 2020
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyHye Kyung Hyun, Eun Ju Cho, Soo Young Park, et al.
Hepatology (Baltimore, Md.)|July 25, 2007
Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppressionByung Chul Yoo, Ju Hyun Kim, Tae-Hun Kim, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis BByung Chul Yoo, Ju Hyun Kim, Young-Hwa Chung, et al.
Yonsei Medical Journal|December 31, 2020
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular CarcinomaJae Seung Lee, Young Eun Chon, Beom Kyung Kim, et al.
Pageof 12